AVITA Medical, Inc.
RCELHealthcareNASDAQMedical Devices
Scan Results
Daily timeframePart of the healthcare sector, AVITA Medical, Inc. (RCEL) is listed under Medical Devices. With a market capitalization of $156.7M, it sits in micro-cap territory. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds and full-thickness skin defects, as well as for repigmentation of stable depigmented vitiligo lesions.
Market Cap
$156.7M
Beta
1.86
P/E (TTM)
—
P/E (Fwd)
-8.60
EPS (TTM)
$-1.55
EPS (Fwd)
$-0.59
ROE
—
ROA
-40.8%
Cash
$14.3M
Total Debt
$48.1M
Free CF
-$18.3M
52W Change
-12.4%
Annual Financials
Cash vs Debt
Where RCEL stands vs its 150-day and 200-day moving averages
As of the July 15, 2026 close, RCEL finished 3.83% below its 150-day moving average ($4.18) and 4.29% below its 200-day moving average ($4.20). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is RCEL overbought or oversold?
At the July 15, 2026 close, RCEL's RSI(14) was 51.7, in neutral territory (between 30 and 70). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
On the balance sheet, RCEL has $14.3M in cash with $48.1M in obligations. The ability to service this debt comfortably depends on continued operational cash generation. Free cash flow is running at -$18.3M, which bears watching. Negative free cash flow can be acceptable during heavy investment periods but needs to improve over time. Revenue has grown from $34.4M (2022) to $71.6M (2025), reflecting a 108% increase over the period.
AVITA Medical, Inc.'s elevated beta suggests the stock experiences more pronounced price movements than the overall market, which increases both upside potential and downside risk. Negative free cash flow means the company is currently spending more than it generates, which may require future fundraising or debt if the trend continues. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence AVITA Medical, Inc.'s trajectory.